1. Shindoh, J, Loyer, EM, Kopetz, S, et al. Optimal morphologic response to preoperative chemotherapy: an alternate outcome end point before resection of hepatic colorectal metastases. J Clin Oncol 2012; 30(36): 4566–4572.
Google Scholar | Crossref | Medline2. Pugh, RN, Murray-Lyon, IM, Dawson, JL, et al. Transection of the oesophagus for bleeding oesophageal varices. Br J Surg 1973; 60(8): 646–649.
Google Scholar | Crossref | Medline | ISI3. Kamath, PS, Kim, WR. The model for end-stage liver disease (MELD). Hepatology 2007; 45(3): 797–805.
Google Scholar | Crossref | Medline | ISI4. Johnson, PJ, Berhane, S, Kagebayashi, C, et al. Assessment of liver function in patients with hepatocellular carcinoma: a new evidence-based approach-the ALBI grade. J Clin Oncol 2015; 33(6): 550–558.
Google Scholar | Crossref | Medline | ISI5. Kobayashi, Y, Kiya, Y, Sugawara, T, et al. Expanded Makuuchi’s criteria using estimated indocyanine green clearance rate of future liver remnant as a safety limit for maximum extent of liver resection. HPB (Oxford) 2019; 21(8): 990–997.
Google Scholar | Crossref | Medline6. Kobayashi, Y, Kiya, Y, Nishioka, Y, et al. Indocyanine green clearance of remnant liver (ICG-Krem) predicts postoperative subclinical hepatic insufficiency after resection of colorectal liver metastasis: theoretical validation for safe expansion of Makuuchi’s criteria. HPB (Oxford) 2019; 22(2): 258–264.
Google Scholar | Crossref | Medline7. Kanda, M, Mizuno, A, Tanaka, C, et al. Nutritional predictors for postoperative short-term and long-term outcomes of patients with gastric cancer. Medicine (Baltimore) 2016; 95(24): e3781.
Google Scholar | Crossref8. Schwegler, I, von Holzen, A, Gutzwiller, JP, et al. Nutritional risk is a clinical predictor of postoperative mortality and morbidity in surgery for colorectal cancer. Br J Surg 2010; 97(1): 92–97.
Google Scholar | Crossref | Medline9. Makuuchi, M, Kosuge, T, Takayama, T, et al. Surgery for small liver cancers. Semin Surg Oncol 1993; 9(4): 298–304.
Google Scholar | Crossref | Medline10. Liver Cancer Study Group of Japan . The general rules for the clinical and pathological study of primary liver cancer, 5th ed. Tokyo, Japan: Kanehara, 2008.
Google Scholar11. Desmet, VJ, Gerber, M, Hoofnagle, JH, et al. Classification of chronic hepatitis: diagnosis, grading and staging. Hepatology 1994; 19(6): 1513–1520.
Google Scholar | Crossref | Medline12. Clavien, PA, Barkun, J, de Oliveira, ML, et al. The Clavien-Dindo classification of surgical complications: five-year experience. Ann Surg 2009; 250(2): 187–196.
Google Scholar | Crossref | Medline | ISI13. Mullen, JT, Ribero, D, Reddy, SK, et al. Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy. J Am Coll Surg 2007; 204(5): 854–862; discussion 862–864.
Google Scholar | Crossref | Medline14. Koch, M, Garden, OJ, Padbury, R, et al. Bile leakage after hepatobiliary and pancreatic surgery: a definition and grading of severity by the International Study Group of Liver Surgery. Surgery 2011; 149(5): 680–688.
Google Scholar | Crossref | Medline15. Forrest, LM, McMillan, DC, McArdle, CS, et al. Evaluation of cumulative prognostic scores based on the systemic inflammatory response in patients with inoperable non-small-cell lung cancer. Br J Cancer 2003; 89(6): 1028–1030.
Google Scholar | Crossref | Medline | ISI16. McMillan, DC, Crozier, JE, Canna, K, et al. Evaluation of an inflammation-based prognostic score (GPS) in patients undergoing resection for colon and rectal cancer. Int J Colorectal Dis 2007; 22(8): 881–886.
Google Scholar | Crossref | Medline | ISI17. Ignacio, de, Ulibarri, J, Gonzalez-Madrono, A, de Villar, NG, et al. CONUT: a tool for controlling nutritional status. First validation in a hospital population. Nutr Hosp 2005; 20(1): 38–45.
Google Scholar18. Galizia, G, Lieto, E, Auricchio, A, et al. Naples prognostic score, based on nutritional and inflammatory status, is an independent predictor of long-term outcome in patients undergoing surgery for colorectal cancer. Dis Colon Rectum 2017; 60(12): 1273–1284.
Google Scholar | Crossref | Medline19. Shindoh, J, Kawamura, Y, Kobayashi, Y, et al. Platelet-albumin score as a sensitive measure for surgical risk prediction and survival outcomes of patients with hepatocellular carcinoma. J Gastrointest Surg 2019; 23(1): 76–83.
Google Scholar | Crossref | Medline20. Zahorec, R . Ratio of neutrophil to lymphocyte counts—rapid and simple parameter of systemic inflammation and stress in critically ill. Bratisl Lek Listy 2001; 102(1): 5–14.
Google Scholar | Medline21. Llovet, JM, Brú, C, Bruix, J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19(3): 329–338.
Google Scholar | Crossref | Medline | ISI22. Kudo, M . Hepatocellular carcinoma 2009 and beyond: from the surveillance to molecular targeted therapy. Oncology 2008; 75(Suppl. 1): 1–12.
Google Scholar | Crossref | Medline23. Kubota, K, Makuuchi, M, Kusaka, K, et al. Measurement of liver volume and hepatic functional reserve as a guide to decision-making in resectional surgery for hepatic tumors. Hepatology 1997; 26(5): 1176–1181.
Google Scholar | Medline24. Kokudo, T, Hasegawa, K, Amikura, K, et al. Assessment of preoperative liver function in patients with hepatocellular carcinoma—the Albumin-Indocyanine Green Evaluation (ALICE) Grade. PLoS ONE 2016; 11(7): e0159530.
Google Scholar | Crossref25. Imamura, H, Seyama, Y, Kokudo, N, et al. One thousand fifty-six hepatectomies without mortality in 8 years. Arch Surg 2003; 138(11): 1198–1206; discussion 1206.
Google Scholar | Crossref | Medline26. Mise, Y, Satou, S, Shindoh, J, et al. Three-dimensional volumetry in 107 normal livers reveals clinically relevant inter-segment variation in size. HPB (Oxford) 2014; 16(5): 439–447.
Google Scholar | Crossref | Medline27. Shindoh, J, Tzeng, CW, Aloia, TA, et al. Safety and efficacy of portal vein embolization before planned major or extended hepatectomy: an institutional experience of 358 patients. J Gastrointest Surg 2014; 18(1): 45–51.
Google Scholar | Crossref | Medline | ISI28. Fagenson, AM, Gleeson, EM, Pitt, HA, et al. Albumin-bilirubin score vs model for end-stage liver disease in predicting post-hepatectomy outcomes. J Am Coll Surg 2020; 230(4): 637–645.
Google Scholar | Crossref | Medline29. Hiraoka, A, Kumada, T, Kudo, M, et al. Albumin-bilirubin (ALBI) grade as part of the evidence-based clinical practice guideline for HCC of the Japan Society of Hepatology: a comparison with the liver damage and Child-Pugh classifications. Liver Cancer 2017; 6(3): 204–215.
Google Scholar | Crossref | Medline30. Takagi, K, Yagi, T, Umeda, Y, et al. Preoperative Controlling Nutritional Status (CONUT) score for assessment of prognosis following hepatectomy for hepatocellular carcinoma. World J Surg 2017; 41(9): 2353–2360.
Google Scholar | Crossref | Medline